A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance

Summary

The purpose of this study is to evaluate the safety and effectiveness of JUVÉDERM products in adults seeking improvement in facial volume and/or skin quality.

Eligibility

Inclusion Criteria:

* Must meet at least 3 of the following criteria for treatment in the face with at least 2 JUVÉDERM products, per investigator's assessment:

  * Minimal, moderate, or severe on Allergan Temple Hollowing Scale (ATHS)
  * Moderate or severe for both eyes on Allergan Infraorbital Hollow Scale (AIHS)
  * Moderate or severe on Allergan Cheek Smoothness Scale (ACSS)
  * Moderate, significant, or severe on Mid-face Volume Deficit Scale (MFVDS)
  * Moderate or severe on Nasolabial Fold Severity Scale (NLFSS)
  * Minimal, mild, or moderate on Allergan Lip Fullness Scale 2 (ALFS2)
  * Moderate or severe on Allergan Chin Retrusion Scale (ACRS)
  * Moderate or severe on Allergan Loss of Jawline Definition Scale (ALJDS)
* Must be in good health as determined by subject's medical history, physical examination, and vital sign measurements.

Exclusion Criteria:

* Prior treatment with non-permanent soft tissue fillers or fat-reducing injectables in the face or neck within 12 months prior to screening.
* Excessively loose skin in the face and/or neck.
* Tendency to develop hypertrophic scarring and/or keloid scarring.

Conditions2

Locations10 sites

Browse More Trials